Steris Corp. share price today

(STE)

Steris Corp. share price is $215.89 & ₹18,283.72 as on 7 Dec 2024, 2.30 'hrs' IST

$215.89

▲

-1.54

(-0.71%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Steris Corp. share price in Dollar and Rupees. Guide to invest in Steris Corp. from India. Also see the sentimental analysis on Indian investors investing in Steris Corp.. Get details on the Indian mutual funds that are investing in Steris Corp.. Get Analyst recommendations and forecasts along with all the Steris Corp.'s financials.

Steris Corp. share price movements

$214.35
$219.30
$215.89
0.72%
Downside
Day's Volatility :2.26%
Upside
1.55%
$197.82
$248.24
$215.89
8.37%
Downside
52 Weeks Volatility :20.31%
Upside
13.03%

Steris Corp. Returns

Period	Steris Corp.	Sector (Health Care)	S&P500
3 Months	-11.43%	-5.7%	12.6%
6 Months	-3.27%	-0.9%	13.9%
1 Year	7.8%	9.9%	32.3%
3 Years	-6.43%	8.4%	29.5%

Steris Corp. Key Statistics

in dollars & INR

Previous Close	$217.43
Open	$217.43
Today's High	$219.3
Today's Low	$214.345
Market Capitalization	$21.5B
Today's Volume	$626.3K
52 Week High	$248.24
52 Week Low	$197.82
Revenue TTM	$5.3B
EBITDA	$1.3B
Earnings Per Share (EPS)	$5.96
PE Ratio	36.48
Dividend Yield	1.05%
Profit Margin	8.16%
Quarterly Earnings Growth YOY	0.31%
Return On Equity TTM	9.27%

How to invest in Steris Corp. from India?

It is very easy for Indian residents to invest directly in Steris Corp. from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Steris Corp. stock in both rupees (INR) and dollars (USD). Search for Steris Corp. or STE on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Steris Corp. or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Steris Corp. shares which would translate to 0.004 fractional shares of Steris Corp. as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Steris Corp.

450%

Period: Sep 8, 2024 to Dec 7, 2024. Change in 30 Days versus previous period

Search volume for Steris Corp. on INDmoney from India has grown in the last 30 days as on Dec 8, 2024. 450% more investors are searching Steris Corp. in the last 30 days versus the previous period.

Indian Mutual Funds that own Steris Corp.

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	847	-3.26	0.04%

Global Institutional Holdings in Steris Corp.

Vanguard Group Inc
12.21%
BlackRock Inc
9.31%
Massachusetts Financial Services Company
6.42%
WCM Investment Management
4.74%
State Street Corp
4.12%
Morgan Stanley - Brokerage Accounts
3.73%

Analyst Recommendation on Steris Corp.

Buy

58%Buy

41%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Steris Corp.(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Steris Corp.

What analysts predicted

Upside of 15.52%

Current:

$215.89

Target:

$249.39

Insights on Steris Corp.

Increasing Revenue
Revenue is up for the last 2 quarters, 1.27B → 1.32B (in $), with an average increase of 3.7% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -1.37M → 150.03M (in $), with an average increase of 52.0% per quarter
Vs BSX
In the last 1 year, Boston Scientific Corp. has given 64.7% return, outperforming this stock by 56.3%
Vs BSX
In the last 3 years, Boston Scientific Corp. has given 117.3% return, outperforming this stock by 123.0%

Steris Corp. Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$2.8B	↑ 6.19%
Net Income	$304.1M	↑ 4.52%
Net Profit Margin	10.93%	↓ 0.17%

	FY20	Y/Y Change
Revenue	$3.0B	↑ 8.94%
Net Income	$407.7M	↑ 34.08%
Net Profit Margin	13.45%	↑ 2.52%

	FY21	Y/Y Change
Revenue	$3.1B	↑ 2.53%
Net Income	$397.4M	↓ 2.52%
Net Profit Margin	12.79%	↓ 0.66%

	FY22	Y/Y Change
Revenue	$4.6B	↑ 47.55%
Net Income	$243.9M	↓ 38.63%
Net Profit Margin	5.32%	↓ 7.47%

	FY23	Y/Y Change
Revenue	$5.0B	↑ 8.13%
Net Income	$107.0M	↓ 56.12%
Net Profit Margin	2.16%	↓ 3.16%

	FY24	Y/Y Change
Revenue	$5.1B	↑ 3.65%
Net Income	$378.2M	↑ 253.4%
Net Profit Margin	7.36%	↑ 5.2%

	Q2 FY23	Q/Q Change
Revenue	$1.3B	↓ 7.24%
Net Income	$123.6M	↓ 34.01%
Net Profit Margin	9.62%	↓ 3.9%

	Q3 FY23	Q/Q Change
Revenue	$1.3B	↑ 4.5%
Net Income	$115.3M	↓ 6.67%
Net Profit Margin	8.59%	↓ 1.03%

	Q4 FY23	Q/Q Change
Revenue	$1.4B	↑ 3.97%
Net Income	$140.7M	↑ 22.05%
Net Profit Margin	10.08%	↑ 1.49%

	Q1 FY24	Q/Q Change
Revenue	$1.4B	↑ 1.7%
Net Income	$-1.4M	↓ 100.98%
Net Profit Margin	-0.1%	↓ 10.18%

	Q2 FY24	Q/Q Change
Revenue	$1.3B	↓ 9.86%
Net Income	$145.4M	↓ 10659.26%
Net Profit Margin	11.36%	↑ 11.46%

	Q3 FY24	Q/Q Change
Revenue	$1.3B	↑ 3.86%
Net Income	$150.0M	↑ 3.19%
Net Profit Margin	11.29%	↓ 0.07%

	FY19	Y/Y Change
Total Assets	$5.1B	↓ 2.45%
Total Liabilities	$1.9B	↓ 4.83%

	FY20	Y/Y Change
Total Assets	$5.4B	↑ 6.95%
Total Liabilities	$2.0B	↑ 6.97%

	FY21	Y/Y Change
Total Assets	$6.6B	↑ 21.18%
Total Liabilities	$2.7B	↑ 32.9%

	FY22	Y/Y Change
Total Assets	$11.5B	↑ 74.2%
Total Liabilities	$4.9B	↑ 82.93%

	FY23	Y/Y Change
Total Assets	$10.8B	↓ 5.51%
Total Liabilities	$4.7B	↓ 3.53%

	FY24	Y/Y Change
Total Assets	$11.1B	↑ 2.23%
Total Liabilities	$4.7B	↑ 0.29%

	Q2 FY23	Q/Q Change
Total Assets	$10.8B	↓ 0.35%
Total Liabilities	$4.6B	↓ 2.72%

	Q3 FY23	Q/Q Change
Total Assets	$11.3B	↑ 4.6%
Total Liabilities	$5.1B	↑ 10.54%

	Q4 FY23	Q/Q Change
Total Assets	$11.4B	↑ 1.37%
Total Liabilities	$5.0B	↓ 1.66%

	Q1 FY24	Q/Q Change
Total Assets	$11.1B	↓ 3.25%
Total Liabilities	$4.7B	↓ 5.17%

	Q2 FY24	Q/Q Change
Total Assets	$10.1B	↓ 8.63%
Total Liabilities	$3.7B	↓ 21.27%

	Q3 FY24	Q/Q Change
Total Assets	$10.2B	↑ 1.32%
Total Liabilities	$3.6B	↓ 2.85%

	FY19	Y/Y Change
Operating Cash Flow	$539.5M	↑ 17.89%
Investing Cash Flow	$-213.2M	↑ 4.61%
Financing Cash Flow	$-294.8M	↓ 17.24%

	FY20	Y/Y Change
Operating Cash Flow	$590.6M	↑ 9.46%
Investing Cash Flow	$-319.7M	↑ 49.95%
Financing Cash Flow	$-163.1M	↓ 44.66%

	FY21	Y/Y Change
Operating Cash Flow	$689.6M	↑ 16.78%
Investing Cash Flow	$-1.2B	↑ 260.97%
Financing Cash Flow	$345.6M	↓ 311.85%

	FY22	Y/Y Change
Operating Cash Flow	$684.8M	↓ 0.7%
Investing Cash Flow	$-666.6M	↓ 42.25%
Financing Cash Flow	$115.8M	↓ 66.49%

	FY23	Y/Y Change
Operating Cash Flow	$756.9M	↑ 10.53%
Investing Cash Flow	$-383.3M	↓ 42.49%
Financing Cash Flow	$-498.7M	↓ 530.56%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$281.1M	↑ 30.27%
Investing Cash Flow	$-66.6M	↓ 14.16%
Financing Cash Flow	$-213.6M	↑ 11.3%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$146.1M	↓ 48.03%
Investing Cash Flow	$-672.8M	↑ 910.32%
Financing Cash Flow	$470.2M	↓ 320.1%

Steris Corp. Technicals Summary

Sell

Neutral

Buy

Steris Corp. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Steris Corp. Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Steris Corp.	-0.8%	-3.27%	7.8%	-6.43%	41.24%
Stryker Corporation	1.73%	9.85%	30.52%	46.79%	93.03%
Boston Scientific Corp.	2.58%	16.93%	63.83%	119.31%	105.7%
Edwards Lifesciences Corp.	9.36%	-15.88%	3.02%	-39.81%	-5.18%
Abbott Laboratories	-0.86%	7.54%	8.82%	-12.78%	36.7%
Medtronic Plc	-4.08%	1.2%	5.54%	-25.41%	-24.23%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Steris Corp.	36.48	36.48	1.2	8.6	0.09	0.05	0.01	66.8
Stryker Corporation	40.99	40.99	2.67	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	74.82	74.82	1.64	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.63	28.63	6.78	2.52	0.19	0.11	NA	16.18
Abbott Laboratories	35.24	35.24	2.25	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	26.38	26.38	1.56	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Steris Corp.	Buy	$21.5B	41.24%	36.48	8.16%
Stryker Corporation	Buy	$145.8B	93.03%	40.99	16.34%
Boston Scientific Corp.	Buy	$133.9B	105.7%	74.82	11.26%
Edwards Lifesciences Corp.	Buy	$42.7B	-5.18%	28.63	65.86%
Abbott Laboratories	Buy	$201.1B	36.7%	35.24	13.99%
Medtronic Plc	Buy	$110.6B	-24.23%	26.38	12.06%

Steris Corp. Dividend announcements

Steris Corp. Dividends December, 2024
In the quarter ending December,2024. Steris Corp. has declared dividend of $0.57
Read More

About Steris Corp.

steris is a leading provider of infection prevention and procedural surgical products and services, focused primarily on healthcare, pharmaceutical, research and medical device customers. our mission is to provide a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. while the corporation was founded as innovative medical technologies in 1985 and renamed steris in 1987, our history dates back to 1894 with the founding of american sterilizer company, a long-time, global leading innovator of sterilization products. today, through a series of strategic acquisitions and continual innovation of new products, steris holds one of the broadest portfolios of products in the industry. it stands at the forefront of efforts to prevent infection and contamination in healthcare, pharmaceutical and medical device environments.

Organization	Steris Corp.
Employees	18000
CEO	Mr. Daniel A. Carestio
Industry	Health Technology

Management People of Steris Corp.

Name	Title
Mr. Daniel A. Carestio	President, CEO & Director
Mr. Michael J. Tokich	Senior VP & CFO
Mr. John Adam Zangerle	Senior VP, General Counsel & Secretary
Ms. Mary Clare Fraser	SVP & Chief Human Resources Officer
Mr. Cary L. Majors	Senior VP & President of Healthcare
Ms. Karen L. Burton	VP & Chief Accounting Officer
Ms. Julie Winter	Vice President of Investor Relations & Corporate Communications
Ms. Julia K. Madsen	Senior VP & GM of Life Sciences
Mr. Andrew Xilas	Senior VP & GM of Dental
Mr. Kenneth E. Kohler	Senior VP & GM of AST

Important FAQs about investing in Steris Corp. from India :

What is Steris Corp. share price today?

Steris Corp. (STE) share price today is $215.89.

Can Indians buy Steris Corp. shares?

Yes, Indians can invest in the Steris Corp. (STE) from India.

With INDmoney, you can buy Steris Corp. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Steris Corp. at zero transaction cost.

How can I buy Steris Corp. shares from India?

It is very easy to buy Steris Corp. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Steris Corp. be purchased?

Yes, you can buy fractional shares of Steris Corp. with INDmoney app.

What are the documents required to start investing in Steris Corp. stocks?

To start investing in Steris Corp., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.